BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12633985)

  • 21. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
    Bladon J; Taylor P
    J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.
    Papp G; Barath S; Szegedi A; Szodoray P; Zeher M
    Clin Rheumatol; 2012 Sep; 31(9):1293-9. PubMed ID: 22706443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photopheresis up-regulates CD36 on monocytes and reduces CD25(+) and CD28(+) T cell numbers.
    Bladon J; Taylor PC
    Photodiagnosis Photodyn Ther; 2005 Jun; 2(2):119-27. PubMed ID: 25048671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.
    Bredberg A; Jonsson S; Lindblom A; Björk P
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):113-9. PubMed ID: 17598863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal photopheresis: from solid organs to face transplantation.
    Hivelin M; Siemionow M; Grimbert P; Lantieri L
    Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies.
    Russell-Jones R
    Br J Dermatol; 2000 Jan; 142(1):16-21. PubMed ID: 10651689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
    Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
    Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy.
    Takasaki Y; Abe K; Tokano Y; Hashimoto H
    Intern Med; 1999 Feb; 38(2):175-7. PubMed ID: 10225679
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro experiments demonstrate that monocytes and dendritic cells are rendered apoptotic by extracorporeal photochemotherapy, but exhibit unaffected surviving and maturing capacity after 30 Gy gamma irradiation.
    Rao V; Saunes M; Jørstad S; Moen T
    Scand J Immunol; 2008 Dec; 68(6):645-51. PubMed ID: 19055700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
    Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
    Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
    Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
    Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs.
    Franklin C; Bruderek K; Schilling B; Brandau S
    J Leukoc Biol; 2019 Aug; 106(2):481-493. PubMed ID: 31075186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B; Behrens W; Hölzle E; Plewig G
    Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
    Siakantaris MP; Tsirigotis P; Stavroyianni N; Argyropoulos KV; Girkas K; Pappa V; Chondropoulos S; Papadavid E; Sakellari I; Anagnostopoulos A; Antoniou C; Dervenoulas J
    Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.